Skip to main content

and
  1. No Access

    Article

    Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL

    V Serafin, V Lissandron, B Buldini, S Bresolin, M Paganin, F Grillo, N Andriano in Leukemia (2017)

  2. No Access

    Article

    Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis

    Acute myeloid leukemia (AML) primary cells express high levels of phosphorylated Akt, a master regulator of cellular functions regarded as a promising drug target. By means of reverse phase protein arrays, we ...

    J Bertacchini, M Guida, B Accordi, L Mediani, A M Martelli, P Barozzi in Leukemia (2014)

  3. Article

    Open Access

    Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups

    S Pillozzi, B Accordi, P Rebora, V Serafin, M G Valsecchi, G Basso, A Arcangeli in Leukemia (2014)

  4. No Access

    Article

    AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells

    The serine/threonine kinase AMP-activated protein kinase (AMPK) and its downstream effectors, including endothelial nitric oxide synthase and BCL-2, are hyperactivated in B-cell precursor-acute lymphoblastic l...

    B Accordi, L Galla, G Milani, M Curtarello, V Serafin, V Lissandron, G Viola in Leukemia (2013)